1-4 of 4
Aya Watanabe, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor

Shoko Oshima, MD, Akihito Shinohara, MD, Hideki Ishida, MD PhD, Miki Umeda, MD, Satoko Osanai, MD, Satoru Itoi, MD, Michiko Ryuzaki, MD, Yuki Izuka, MD, Aya Watanabe, MD, Norina Tanaka, MD PhD, Midori Ishiyama, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Shotaro Hagiwara, MD PhD, Masayuki Shiseki, MD PhD, Junji Tanaka, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2910.
https://doi.org/10.1182/blood-2019-125601
Published: 2019
Journal Articles

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Norina Tanaka, MD PhD, Aya Watanabe, MD, Suguru Honda, MD, Mitsuko Kobayashi, Yan-Hua Wang, MD, Yuki Iizuka, MD, Michiko Ryuzaki, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Katsunori Ikari, MD PhD, Masayuki Shiseki, MD PhD, Masayoshi Harigai, MD PhD, Junji Tanaka, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5219.
https://doi.org/10.1182/blood-2019-127836
Published: 2019
Journal Articles

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Shotaro Hagiwara, MD PhD, Yan-Hua Wang, MD, Hirohito Kobayashi, MD, Yutaka Kato, MD, Norina Tanaka, MD PhD, Yuki Iizuka, MD, Aya Watanabe, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD PhD, Hitoshi Kanno, MD PhD, Junji Tanaka, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3133.
https://doi.org/10.1182/blood-2019-127739
Published: 2019
Journal Articles

Fractionated ICE with Rituximab Is Safe and Effective for Relapse/Refractory DLBCL Patients with Severe Comorbidities

Norina Tanaka, MD PhD, Yoichi Imai, MD PhD, Aya Watanabe, MD, Kenjiro Mitsuhashi, MD PhD, Kentaro Yoshinaga, MDPhD, Masayuki Shiseki, MD PhD, Naoki Mori, MD PhD, Junji Tanaka, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 2713.
https://doi.org/10.1182/blood.V126.23.2713.2713
Published: 2015